MedImmune's Brian Rosen Honored by Montgomery County Chamber at 49th Annual Awa... ( GAITHERSBURG Md. June 6 /- MedImm...)

MedImmune's Brian Rosen Honored by Montgomery County Chamber at 49th Annual Awards Dinner

Date:6/6/2008

GAITHERSBURG, Md., June 6 /PRNewswire/ -- MedImmune, the global biologics unit of AstraZeneca, announced today that the Montgomery County Chamber of Commerce has presented Brian Rosen, senior director, government affairs, with its 2008 Chairman's Award at the organization's 49th Annual Dinner held recently at the Bethesda North Marriott Hotel and Conference Center.

"The Montgomery County Chamber of Commerce plays a vital role in representing the local business community at the regional and state levels, which is why MedImmune is proud to be an active corporate member," said Lori Weiman, vice president of public affairs. "We are pleased that the chamber has chosen to recognize Brian's commitment to its organization with the chairman's award."

The Montgomery County Chamber of Commerce Annual Chairman's Award recognizes an individual for outstanding service and contributions to the business community. Mr. Rosen has represented MedImmune as a board member of the Montgomery County Chamber for the past five years. He is currently the co-chair for the legislative affairs committee and a member of the executive committee and the board of directors.

About MedImmune

MedImmune is wholly owned by AstraZeneca plc (LSE: AZN.L, NYSE: AZN) and is the worldwide biologics business for the AstraZeneca Group. The company has approximately 3,000 employees worldwide and is headquartered in Gaithersburg, Maryland. MedImmune strives to provide better medicines to patients, new medical options for physicians and rewarding careers to employees. Dedicated to advancing science and medicine to help people live better lives, the company is focused on infection, oncology, respiratory disease and inflammation, cardiovascular/gastrointestinal disease and neuroscience. For more information, visit MedImmune's website at http://www.medimmune.com.

SOURCE MedImmune
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Post Your Comments:

(Date:1/15/2014)... IPSWICH, England , January 15, 2014 ... whether technology developed to win races on the Formula ... obesity. This unique healthcare collaboration between McLaren Applied Technologies ... academics at University Campus Suffolk is being funded by ... inspired by equipment used to collect data about the ...

(Date:1/15/2014)... The Microcompetition with Foreign DNA theory explains how ... these latent viruses is the Epstein Barr Virus (EBV), ... Rheumatoid arthritis (RA) is a chronic inflammatory disease that ... a study found that RA patients have high concentrations ... What is Microcompetition? , Dr. Hanan Polansky discovered that ...

(Date:1/15/2014)... 15, 2014 Freeslate, Inc ... solutions, today announced that Lupin Limited, one of ... of Freeslate’s CM Protégé PharmD System ... Lupin, headquartered in Mumbai, India, is focused on ... branded formulations and Active Pharmaceutical Ingredients (APIs) for ...

(Date:1/14/2014)... (PRWEB) January 14, 2014 Date: Friday, ... p.m. , Location: Warrington Country Club, 1360 Almshouse Road, ... Foundation, the only national nonprofit organization solely dedicated to ... quality of life for those affected worldwide, will host ... Warrington Country Club in Warrington, Pa. , Each ...

Breaking Biology Technology:Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2 Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3 Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4 Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2 Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3 Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2 Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3 Hepatitis B Foundation to Host Annual Crystal Ball Gala 2

[0] Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership [0] Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition [0] Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development [0] Hepatitis B Foundation to Host Annual Crystal Ball Gala

... 4, 2010 PharmaNet Development Group, Inc., a leading ... generic drug and medical device companies, today announced that ... scientists at the 2010 American Association of Pharmaceutical Scientists ... 14 -18 at the Ernest N. Morial Convention Center ...

... <meta name="description" content="bioMerieux and Biocartis Sign Strategic Partnership in Molecular Diagnostics. ... due for launch in 2012,bioMerieux gains exclusive rights in microbiology,bioMerieux takes ... Strategic Partnership in Molecular... -- MARCY L,ETOILE, France and LAUSANNE, Switzerland, ... ...

... NEW YORK, Nov. 4, 2010 Reportlinker.com ... is available in its catalogue: ... and developer strategies for success ... developers have long been under pressure to ...

PharmaNet to Present More Than 20 Posters at the 2010 American Association of Pharmaceutical Scientists Annual Meeting bioMerieux and Biocartis Sign Strategic Partnership in Molecular Diagnostics Building Biotech Technology Transfer Opportunities: Sponsor and Developer Strategies for Success

(Date:3/10/2014)... from Boston Children,s Hospital,s Phase 1 human clinical ... A team of investigators successfully completed a Phase ... growth factor 1 (IGF-1)], showing proof-of-principle that treatments ... of Rett syndrome, are possible. The study ... in girls diagnosed with Rett syndrome, and the ...

(Date:3/10/2014)... of a traumatic brain injury, better known as a ... team of researchers at the University of Pennsylvania is ... play in this kind of injury, with an eye ... Their recent findings, published in the Biophysical Journal ... a critical brain protein and its role in the ...

(Date:3/10/2014)... that captured the public,s imagination over the years, but ... of them all sunlight and electricity. , ... Professor of the Natural Sciences, and Arpita Bose, a ... of researchers showed that the commonly found bacterium ... electrons from minerals located deep in soil and sediment ...

Breaking Biology News(10 mins):Mecasermin (rh-IGF-1) treatment for Rett Syndrome is safe and well-tolerated 2 Penn researchers model a key breaking point involved in traumatic brain injury 2 Penn researchers model a key breaking point involved in traumatic brain injury 3 Penn researchers model a key breaking point involved in traumatic brain injury 4 A shocking diet 2 A shocking diet 3

[0] Mecasermin (rh-IGF-1) treatment for Rett Syndrome is safe and well-tolerated [0] Penn researchers model a key breaking point involved in traumatic brain injury [0] A shocking diet

... our forest sector, according to The State of Canada's ... Natural Resources Canada, presented the report today at the ... industry competitiveness is well chosen," said Minister Lunn. "Canada's ... and meet the challenges of a changing marketplace. It ...

... A jumping gene first identified in a cabbage-eating moth may ... gene therapy, researchers say. , , They compared the ... insert themselves into a cell's DNA and produce a desired ... radiation therapy. , They found the piggyBac transposon was five ...

... have discovered in mouse models that a gene called ... lens development in the eye of the mammalian embryo. ... in patients with holoprosencephaly, a disease that can cause ... fail to divide normally into two lobes. Holoprosencephaly is ...

Cached Biology News:Report highlights change in Canada's forests 2 Jumping gene could provide non-viral alternative for gene therapy 2 Jumping gene could provide non-viral alternative for gene therapy 3 Key gene controlling eye lens development identified 2

Report highlights change in Canada's forests Jumping gene could provide non-viral alternative for gene therapy Key gene controlling eye lens development identified

Standard 2" or 3" Plastic can be ordered with 81 or 100 cell dividers. Mini 2" Plastics Boxes come standard with 25 cell dividers. Plastic boxes can also be ordered with corresponding freezer racks...

Ultra Pure Grade. Used in conjunction with IPTG to identify bacterial colonies that contain recombinant plasmids by blue/white selection. X-Gal forms an intense blue precipitate in the presence of be...

Request Info...

4-Hydroxy-3-nitrophenylacetyl hapten is conjugated to KLH (Keyhole Limpet Hemocyanin) lysine through amide bonds....

Biology Products:

Plastics Boxes from LABREPCO, Inc.X-GAL (5-Bromo-4-Chloro-3-Indolyl-Beta-D-Galactopyranoside), = 99.0% from AMRESCO, Inc.DTNB/EGTA from Cayman Chemical Keyhole Limpet Hemocyanin NP-KLH (Keyhole Limpet Hemocyanin), Unconjugated from Biosearch Technologies